Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin - Li, Bo; Zhao, Xin; Zhang, Lei; Cheng, Wen (Frontiers in Oncology, 2021)